Latest news with #Spiromesifen
&w=3840&q=100)
Business Standard
03-07-2025
- Business
- Business Standard
Indogulf Cropsciences makes flat D-street debut, lists at ₹111 on BSE
Indogulf Cropsciences IPO listing: Indogulf Cropsciences made a flat stock market debut on Thursday, July 3, 2025, listing at ₹111 per share on the BSE. On the NSE, the stock opened at ₹111 the upper end price. Post-listing, the stock was trading at ₹110.5, down 0.4 per cent from the listing price. Indogulf Cropsciences shares underperformed its grey market expectations. Prior to the listing, the company's shares were commanding a grey market premium (GMP) of ₹18, or 16.2 per cent, with unofficial trading quoting the stock at ₹129 apiece, according to market sources. Indogulf Cropsciences IPO details The ₹200 crore IPO comprised a fresh issue of 14.4 million shares aggregating to ₹160 crore and an offer for sale (OFS) of 3.6 million shares worth ₹40 crore. The IPO was open for bidding between June 26 and June 30, 2025, with allotment finalised on July 1. The Indogulf Cropsciences IPO price band was set in the range of ₹105-₹111 per share. Retail investors were required to bid for a minimum of one lot comprising 135 shares worth ₹14,985 at the upper end price. Bigshare Services was the issue registrar. Systematix Corporate Services was the sole book-running lead manager. According to the red herring prospectus (RHP), the company plan to use ₹65 crore from the net fresh issue proceeds for funding its working capital requirements and ₹34.12 crore for repayment or prepayment of certain outstanding borrowings. In addition, ₹14 crore will be used for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat in Haryana. The remaining funds will be used for general corporate purposes. About Indogulf Cropsciences Incorporated in 1993, New Delhi-based Indogulf Cropsciences specialises in manufacturing crop protection products, plant nutrients, and biologicals in India. It manufactures Spiromesifen technical with 96.5 per cent purity and is one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical with 97 per cent purity in India. The company manufactures and markets an extensive range of crop protection products, plant nutrients, and biologicals in India. Indogulf Cropsciences operates four manufacturing facilities including one in Samba (Jammu & Kashmir), two in Nathupur (Haryana) and one in Barswani, (Haryana). The company's diverse product portfolio caters to various crops, including cereals, pulses and oilseeds, fibre crops, plantations, and fruits and vegetables.
&w=3840&q=100)
Business Standard
01-07-2025
- Business
- Business Standard
Indogulf Cropsciences IPO allotment today; check status, GMP, listing date
Indogulf Cropsciences IPO allotment status: The basis of allotment of shares for Indogulf Cropsciences is expected to be finalised today, Tuesday, July 1, 2025. The initial public offering (IPO) of the Delhi-based agrochemical company, which closed for bidding on Monday, June 30, received a solid response on the third and final day of the bidding from all the categories of investors. The issue was subscribed around 40 per cent on the first day and ended the day with around 93 per cent subscription. According to NSE data, investors made bids for 347.26 million shares or 25.98 times, compared to the 13.36 million shares on offer by 5 PM on Monday. The portion allocated for qualified institutional bidders (QIBs) was subscribed 33.26 times, while the non-institutional investors (NIIs) portion saw a subscription of 48.39 times. The quota set aside for retail investors was booked 14.78 times at the same time. The employee portion was booked only 1.09 times. After the allotment process is completed, investors can verify their IPO allotment status by visiting, the official websites of the National Stock Exchange (NSE), BSE, and Bigshare Services, the registrar for the issue. Alternatively, investors can use the direct links provided below to check their allotment status: Check Indogulf Cropsciences IPO allotment status on BSE: Indogulf Cropsciences IPO grey market premium (IPO) The unlisted shares of Indogulf Cropsciences were trading at ₹123 in the grey market, commanding a premium of ₹12 or 10.8 per cent compared to the upper price band of ₹111 per share, according to sources tracking unofficial markets. Indogulf Cropsciences IPO details The Delhi-based agrochemical company aims to raise ₹200 crore through a public issue, which comprises a fresh share sale of ₹160 and an offer for sale (OFS) of up to 3.6 million shares worth ₹40 crore. Shares of Indogulf Cropsciences are scheduled to be listed on the bourses, NSE and BSE, on Thursday, July 3. Indogulf Cropsciences IPO was available at a price band of ₹105-111 per share Systematix Corporate Services is the sole book-running lead manager. According to the red herring prospectus (RHP), the company intends to utilise ₹65 crore from the net fresh issue proceeds for funding its working capital requirements and ₹34.12 crore for repayment or prepayment of certain outstanding borrowings. In addition, ₹14 crore will be used for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat in Haryana. The remaining funds will be used for general corporate purposes. About Indogulf Cropsciences Incorporated in 1993, New Delhi-based Indogulf Cropsciences specialises in manufacturing crop protection products, plant nutrients, and biologicals in India. It manufactures Spiromesifen technical with 96.5 per cent purity and is one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical with 97 per cent purity in India. The company manufactures and markets an extensive range of crop protection products, plant nutrients, and biologicals in India. Indogulf Cropsciences operates four manufacturing facilities including one in Samba (Jammu & Kashmir), two in Nathupur (Haryana) and one in Barswani, (Haryana). The company's diverse product portfolio caters to various crops, including cereals, pulses and oilseeds, fibre crops, plantations, and fruits and vegetables.
Mint
26-06-2025
- Business
- Mint
Indogulf Cropsciences IPO Day 1 Live: Check GMP, subscription status, review, key dates. Apply or not?
The initial public offering (IPO) of Indogulf Cropsciences, a producer of crop protection products, has opened for subscription starting today, June 26, and will close on June 30, Monday. Prior to its public offering, the company secured ₹ 58.20 crores from anchor investors. Indogulf Cropsciences IPO price band has been fixed in the range of ₹ 105 to ₹ 111 per equity share of the face value of ₹ 10. The Indogulf Cropsciences IPO lot size is 135 equity shares and in multiples of 135 equity shares thereafter. Indogulf Cropsciences IPO has reserved not more than 50% of the shares in the public issue for qualified institutional buyers (QIB), not less than 15% for non-institutional Institutional Investors (NII), and not less than 35% of the offer is reserved for retail investors. The allocation of shares for the Indogulf Cropsciences IPO is expected to be determined on Tuesday, July 1, with refunds beginning on Wednesday, July 2. On the same day following the refunds, shares will be deposited into the demat accounts of the successful applicants. The listing price for Indogulf Cropsciences shares is anticipated to be announced on the BSE and NSE on Thursday, July 3. Indogulf Cropsciences Limited focuses on the production of crop protection products, plant nutrients, and biological solutions within India. In 2019, the company achieved the successful production of Spiromesifen technical with a purity level of 96.5% and became one of the first domestic manufacturers of Pyrazosulfuron Ethyl technical with 97% purity in India. The company operates four manufacturing facilities across Samba (Jammu & Kashmir) and Nathupur (Haryana), occupying approximately twenty acres, which includes two locations in Nathupur and one in Barwasni, Haryana. Indogulf boasts a distribution network that spans 22 states and 3 Union Territories in India, backed by 169 business partners, 5,772 distributors, and 129 collaborators in 34 countries globally. According to the red herring prospectus (RHP), the company's listed peers include Aries Agro Ltd (with a P/E ratio of 17.47), Basant Agro Tech India Ltd (with a P/E ratio of 44.58), Best Agrolife Ltd (with a P/E ratio of 12.23), Bhagiradha Chemicals & Industries Ltd (with a P/E ratio of 101.81), Heranba Industries Ltd (with a P/E ratio of 35.34), India Pesticides Ltd (with a P/E ratio of 41.62), and Dharmaj Crop Guard Ltd (with a P/E ratio of 18.02). Subscription for the public issue will open at 10:00 IST during Thursday's deals. According to Anand Rathi Research, in terms of valuation, the company is targeting a PE ratio of 24.6 times based on annualized FY25 figures, resulting in a post-issue market capitalisation of ₹ 7,015 million, making the offering reasonably priced. Despite experiencing fluctuations in raw material prices over the past few years, the firm has demonstrated consistent growth in both its revenue and profits. The brokerage is confident that the company is positioned for long-term growth, supported by its backward-integrated manufacturing capabilities, dedicated research and development efforts, robust distribution and sales network, and a diverse range of products. 'Since the industry that company caters is cyclical, highly dependent on government's initiatives, shift in consumer preference for organic production and with its fully priced scenario we believe that, the company is long run growth story which requires timely mass initiatives for agricultural boost, increase awareness of sustainable farming. So we give 'SUBSCRIBE' rating for the issue,' said the brokerage. The IPO consists of a new issuance of equity shares valued at ₹ 160 crore and a share sale of up to 36.03 lakh shares from promoters Om Prakash Aggarwal (HUF) and Sanjay Aggarwal (HUF). The funds raised from the new issuance, amounting to ₹ 65 crore, will be allocated for meeting working capital needs, while ₹ 34.12 crore will go towards debt repayment, ₹ 14 crore for capital expenditures, and general corporate uses. Systematix Corporate Services serves as the exclusive book-running lead manager, while Bigshare Services will act as the registrar for the issue. Indogulf Cropsciences IPO GMP today or grey market premium is +11. This indicates Indogulf Cropsciences share price were trading at a premium of ₹ 11 in the grey market on Thursday, according to Considering the upper end of the IPO price band and the current premium in the grey market, the estimated listing price of Indogulf Cropsciences share price was indicated at ₹ 122 apiece, which is 9.91% higher than the IPO price of ₹ 111. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
23-06-2025
- Business
- Mint
Indogulf Cropsciences IPO: Price band set at ₹105-111 per share; check issue details, key dates, more
Indogulf Cropsciences IPO price band has been fixed in the range of ₹ 105 to ₹ 111 per equity share of the face value of ₹ 10. The Indogulf Cropsciences IPO date of subscription is scheduled for Thursday, June 26 and will close on Monday, June 30. The allocation to anchor investors for the Indogulf Cropsciences IPO is scheduled to take place on Wednesday, June 25. The floor price is 10.50 times the face value of the equity shares and the cap price is 11.10 times the face value of the equity shares. The Indogulf Cropsciences IPO lot size is 135 equity shares and in multiples of 135 equity shares thereafter. Indogulf Cropsciences IPO has reserved not more than 50% of the shares in the public issue for qualified institutional buyers (QIB), not less than 15% for non-institutional Institutional Investors (NII), and not less than 35% of the offer is reserved for retail investors. Tentatively, Indogulf Cropsciences IPO basis of allotment of shares will be finalised on Tuesday, July 1 and the company will initiate refunds on Wednesday, July 2, while the shares will be credited to the demat account of allottees on the same day following refund. Indogulf Cropsciences share price is likely to be listed on BSE and NSE on Thursday, July 3. Indogulf Cropsciences Limited specializes in the production of crop protection products, plant nutrients, and biological solutions in India. In 2019, the company produced Spiromesifen technical with a purity level of 96.5% and became one of the pioneering local producers of Pyrazosulfuron Ethyl technical with 97% purity in India. The company has four manufacturing plants located in Samba (Jammu & Kashmir) and Nathupur (Haryana), spanning around twenty acres, which includes two sites in Nathupur and one in Barwasni, Haryana. Indogulf has a distribution network that extends to 22 states and 3 Union Territories across India, supported by 169 business partners, 5,772 distributors, and 129 partners in 34 countries around the world. As per the red herring prospectus, the company's listed peers are Aries Agro Ltd (with a P/E of 17.47), Basant Agro Tech India Ltd (with a P/E of 44.58), Best Agrolife Ltd (with a P/E of 12.23), Bhagiradha Chemicals & Industries Ltd (with a P/E of 101.81), Heranba Industries Ltd (with a P/E of 35.34), India Pesticides Ltd (with a P/E of 41.62), and Dharmaj Crop Guard Ltd (with a P/E of 18.02). Indogulf Cropsciences IPO comprises a fresh issue of ₹ 160 crore, and an offer-for-sale (OFS) of 36,03,603 equity shares by the promoter group selling shareholder. Indogulf Cropsciences IPO aims to allocate the net proceeds from the issue for various purposes, including meeting working capital needs, repaying or prepaying debts, funding capital expenditures for the company, or establishing an in-house dry flowable (DF) facility in Haryana, as well as for general corporate activities. Systematix Corporate Services Limited serves as the book-running lead manager for the Indogulf Cropsciences IPO, whereas Bigshare Services Pvt Ltd acts as the registrar for this issue. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
